Get the Stockscreener App
37.75
0.05%
-0.02
After Hours:
37.74
-0.010
-0.03%
Pacs Group Inc stock is traded at $37.75, with a volume of 933.86K.
It is down -0.05% in the last 24 hours and up +7.86% over the past month.
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.
See More
Previous Close:
$37.77
Open:
$38.18
24h Volume:
933.86K
Relative Volume:
1.06
Market Cap:
$5.97B
Revenue:
$5.29B
Net Income/Loss:
$191.46M
P/E Ratio:
32.03
EPS:
1.1785
Net Cash Flow:
$298.82M
1W Performance:
+0.72%
1M Performance:
+7.86%
6M Performance:
+37.27%
1Y Performance:
+285.20%
1-Day Range:
$37.70
$39.30
1-Week Range:
$35.05
$39.30
52-Week Range:
$7.50
$43.08
Pacs Group Inc Stock (PACS) Company Profile
Name
Pacs Group Inc
Sector
Industry
Phone
(801) 447-9829
Address
90 S. 400 W. SUITE 700, SALT LAKE CITY
Compare PACS vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PACS
Pacs Group Inc
|
37.75 | 5.98B | 5.29B | 191.46M | 298.82M | 1.1785 |
HCA
Hca Healthcare Inc
|
394.07 | 87.09B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
173.78 | 15.33B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
198.52 | 12.75B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.64 | 12.09B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
104.96 | 10.36B | 6.07B | 793.80M | 464.40M | 5.9914 |
Pacs Group Inc Stock (PACS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-25 | Resumed | JP Morgan | Overweight |
| Dec-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-06-24 | Resumed | JP Morgan | Overweight |
| Oct-09-24 | Initiated | UBS | Buy |
| Sep-11-24 | Resumed | Citigroup | Buy |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| May-06-24 | Initiated | Citigroup | Buy |
| May-06-24 | Initiated | JP Morgan | Overweight |
| May-06-24 | Initiated | Oppenheimer | Outperform |
| May-06-24 | Initiated | RBC Capital Mkts | Outperform |
| May-06-24 | Initiated | Stephens | Overweight |
| May-06-24 | Initiated | Truist | Buy |
View All
Pacs Group Inc Stock (PACS) Latest News
PACS Group Growth Story Gains Attention Amid Healthcare Expansion - Kalkine Media
PACS Group Q1 earnings call highlights - MSN
PACS Stock Chart | PACS GROUP INC (NYSE:PACS) - ChartMill
PACS Stock Price, Quote & Chart | PACS GROUP INC (NYSE:PACS) - ChartMill
Bronstein, Gewirtz & Grossman, LLC Is Investigating PACS Group, Inc. (PACS) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating PACS Group, I - The National Law Review
PACS Group chief legal officer sells $3.02 million in company stock - Investing.com
[Form 4] PACS Group, Inc. Insider Trading Activity - Stock Titan
PACS Maintains Buy Rating by Truist Securities -- Price Target R - GuruFocus
Earnings call transcript: PACS Group Q1 2026 beats EPS forecast - Investing.com UK
PACS Group Price Target Raised to $52.00/Share From $50.00 by Truist Securities - Moomoo
PACS Group Is Maintained at Buy by Truist Securities - Moomoo
Earnings call transcript: PACS Group Q1 2026 beats EPS forecast By Investing.com - Investing.com Australia
How Pacs Group Inc. (PACS) Affects Rotational Strategy Timing - Stock Traders Daily
Truist Raises Price Target on PACS Group to $52 From $50, Keeps Buy Rating - Moomoo
Big U.S. nursing-home group okays $250M buyback after 184% profit jump - Stock Titan
PACS Group's (NYSE:PACS) Earnings May Just Be The Starting Point - 富途牛牛
PACS Group's (NYSE:PACS) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Truist raises PACS Group stock price target to $52 on guidance - Investing.com Canada
PACS Investors Have Opportunity to Lead PACS Group Inc. Securities Fraud Lawsuit - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PACS Group, Inc. (PACS) And Encourages Shareholders to Reach Out - ACCESS Newswire
Is PACS Group (NYSE:PACS) Gaining From NYSE Healthcare Growth? - Kalkine Media
PACS Group (PACS) CFO awarded 48,426 RSUs vesting over three years - Stock Titan
[144] PACS Group, Inc. SEC Filing - Stock Titan
PACS Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Sahm
Why PACS Group Stock Is Getting Hammered Today - TipRanks
UBS Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $50 - Moomoo
PACS Group(PACS) Stock Options Chain | Quotes & News - Moomoo
Results: PACS Group, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Moomoo
UBS Lifts PACS Group Price Target to $50 From $44, Maintains Buy Rating - marketscreener.com
PACS Group Q1 Earnings Call Highlights - sharewise.com
PACS Group (PACS) Is Up 22.1% After Q1 Beat, Guidance Hike and Buyback Launch - Yahoo Finance
Truist Financial Maintains PACS Group(PACS.US) With Buy Rating - Moomoo
PACS Group: Strong Comeback That’s Backed By Improving Fundamentals (NYSE:PACS) - Seeking Alpha
PACS Group | 10-K: FY2025 Annual Report - Moomoo
PACS Group stock rises as RBC Capital maintains Outperform rating By Investing.com - Investing.com India
PACS Group stock rises as RBC Capital maintains Outperform rating - Investing.com UK
RBC Capital Maintains PACS Group(PACS.US) With Buy Rating, Maintains Target Price $52 - Moomoo
Oppenheimer Adjusts Price Target on PACS Group to $48 From $42, Maintains Outperform Rating - marketscreener.com
PACS Group Q1 2026: Revenue Up 11%, EBITDA Surges 75%, But Is the Stock Now Overpriced? - TIKR.com
Assessing PACS Group (PACS) Valuation After Q1 Earnings Beat And New US$250 Million Buyback - Yahoo Finance
Pacs Group Inc Stock (PACS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.50%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):